This independent RP-HPLC lab test confirms Semaglutide 10mg from Orbitrex Peptides at 98.306% purity. The analysis was conducted by Chromate on October 18, 2025.
Semaglutide is a GLP-1 receptor agonist researched for its potential effects on metabolic regulation, weight management, and glycemic control. A purity level of 98.306% indicates minimal contamination and high-grade synthesis.
Endotoxin testing confirmed < 0.0444 EU/mg, and heavy metal analysis showed < 100 ppb, demonstrating safety standards for research applications. The full certificate of analysis is available for download on this page.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.